Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Siplizumab

EU orphan designation number: EU/3/06/383
Active ingredient: Siplizumab
Indication: Treatment of T-cell and NK-cell neoplasms
Sponsor: MedImmune, LLC
Lagelandseweg 78, 6545 CG Nijmegen, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/07/2006 Orphan designation EMEA/OD/012/06 (2006)3094 of 29/06/2006
15/10/2009 Change of name and/or address of sponsor
13/03/2013 Removal of orphan designation from Community Register